Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | PGR | P06401 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | RARA | P10276 | 1/20 | 0.30 |
| ▸ | RARB | P10826 | 1/20 | 0.30 |
| ▸ | RARG | P13631 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4956295 | 0.84 | ALB (0.31) | KMT2ACYP3A4MAPTMEN1 | |
| SCHEMBL4606222 | 0.82 | KMT2A (0.34) | KMT2AMEN1 | |
| SCHEMBL12339885 | 0.78 | ALDH1A1 (0.35) | KMT2AMAPTPGRMEN1 | |
| SCHEMBL211920 | 0.73 | ERN1 (0.39) | KMT2AMAPTPGRMEN1 | |
| SCHEMBL6760934 | 0.72 | CA1 (0.31) | — | |
| SCHEMBL4607854 | 0.71 | KMT2A (0.39) | KMT2ACYP3A4MAPTMEN1RARA | |
| SCHEMBL2048427 | 0.71 | ACHE (0.43) | KMT2APGRMEN1 | |
| SCHEMBL549398 | 0.70 | MEN1 (0.38) | KMT2ACYP3A4MAPTMEN1RARA | |
| SCHEMBL4953194 | 0.69 | — | — | |
| SCHEMBL2090099 | 0.68 | ERN1 (0.32) | KMT2APGRMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7456323-B2 | 1,3-bis(3-formyl-4-hydroxyphenyl)adamantanes and polynuclear polyphenols derived therefrom | HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) | 2008-11-25 | — | — | US | disclosed |
| US-20080242896-A1 | 1,3-Bis(3-Formyl-4-Hydroxyphenyl)Adamantanes and Polynuclear Polyphenols Derived Therefrom | HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) | 2008-10-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080242896-A1 | 1,3-Bis(3-Formyl-4-Hydroxyphenyl)Adamantanes and Polynuclear Polyphenols Derived Therefrom | HNMT, NEFM, CD69 | KMT2A 2847/4885CYP3A4 1801/4885MAPT 1284/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.